Vijay Sagar Madamsetty

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Debabrata Mukhopadhyay · 8 shared papers, 2019–2025 · strength 1.04
   • Paper Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/pharmaceutics17101334↗
   • Paper Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Can… DOI 10.3390/cancers12051189↗
   • Paper Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Sta… DOI 10.3390/cancers13164048↗
2. Krishnendu Pal · 5 shared papers, 2019–2025 · strength 0.74
   • Paper Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/pharmaceutics17101334↗
   • Paper Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Can… DOI 10.3390/cancers12051189↗
   • Paper Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineere… DOI 10.1039/c9nr05478b↗
3. Hari Krishnareddy Rachamala · 1 shared paper, 2025 · strength 0.30
   • Paper Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/pharmaceutics17101334↗
4. Bengt Fadeel · 2 shared papers, 2019 · strength 0.20
   • Paper Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineere… DOI 10.1039/c9nr05478b↗
   • Paper Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer. DOI 10.1016/j.nano.2019.02.020↗
5. Sneha Vivekanandhan · 1 shared paper, 2021 · strength 0.12
   • Paper Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Sta… DOI 10.3390/cancers13164048↗
6. David Kuang-Fu Chang · 1 shared paper, 2021 · strength 0.12
   • Paper Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Sta… DOI 10.3390/cancers13164048↗
7. Min‐Sik Kim · 1 shared paper, 2021 · strength 0.11
   • Paper Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeu… DOI 10.3390/cancers13143404↗
8. Santosh Renuse · 1 shared paper, 2021 · strength 0.11
   • Paper Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeu… DOI 10.3390/cancers13143404↗
9. Rondell Patrell Graham · 1 shared paper, 2021 · strength 0.11
   • Paper Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeu… DOI 10.3390/cancers13143404↗
10. Mark Joseph Truty · 1 shared paper, 2021 · strength 0.11
    • Paper Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeu… DOI 10.3390/cancers13143404↗
11. Akhilesh Pandey · 1 shared paper, 2021 · strength 0.11
    • Paper Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeu… DOI 10.3390/cancers13143404↗
12. Hsu‐Shan Huang · 1 shared paper, 2019 · strength 0.09
    • Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632↗
13. Kabir Mody · 1 shared paper, 2019 · strength 0.09
    • Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632↗
14. Jin‐San Zhang · 1 shared paper, 2019 · strength 0.08
    • Paper Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-M… DOI 10.1158/1078-0432.ccr-19-0799↗
15. Li Ding · 1 shared paper, 2019 · strength 0.08
    • Paper Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-M… DOI 10.1158/1078-0432.ccr-19-0799↗
16. Daniel D. Billadeau · 1 shared paper, 2019 · strength 0.08
    • Paper Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-M… DOI 10.1158/1078-0432.ccr-19-0799↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.